Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Aarhus
Albert Einstein College of Medicine
Shanghai Pulmonary Hospital, Shanghai, China
Rutgers, The State University of New Jersey
Massachusetts General Hospital
Fundación GECP
Medipol University
RenJi Hospital
The First Affiliated Hospital of Guangzhou Medical University
Instituto Nacional de Cancerologia de Mexico
Yale University
Fundación GECP
Fundación GECP
Fundación GECP
Fundación GECP
Fundación GECP
Stanford University
Stanford University
University of Washington
European Institute of Oncology
Universitair Ziekenhuis Brussel
Assiut University
University of California, Irvine
McGill University Health Centre/Research Institute of the McGill University Health Centre
Azienda Sanitaria-Universitaria Integrata di Udine
University of New Mexico
Nanfang Hospital, Southern Medical University
The University of Queensland
University Hospital Augsburg
Johannes Gutenberg University Mainz
European Institute of Oncology
Sichuan Cancer Hospital and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Fundación GECP
H. Lee Moffitt Cancer Center and Research Institute
Lung Clinic Hemer
Erasme University Hospital
Post Graduate Institute of Medical Education and Research, Chandigarh
Ain Shams University
The Methodist Hospital Research Institute
University of Louisville
Sichuan Cancer Hospital and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Hallym University Kangnam Sacred Heart Hospital
University Health Network, Toronto
Sichuan Cancer Hospital and Research Institute
St. Joseph's Healthcare Hamilton
Shanghai Pulmonary Hospital, Shanghai, China
Radboud University Medical Center